Lee Jaewon, Lee Sang-Hoon
194Department of Chemical Engineering, Carnegie Institute of Technology, Carnegie Mellon University, Pittsburgh, PA USA.
294Department of Biomedical Engineering, College of Health Science, Korea University, Jeongneung-dong, Seongbuk-gu, Seoul, 136-703 Republic of Korea.
Biomed Eng Lett. 2013 Aug 1;3(2):59-66. doi: 10.1007/s13534-013-0094-y. eCollection 2013 Jun.
As the point of care diagnosis devices are becoming ever more popular, this paper suggest a miniaturized testing device from a drop of blood to diagnosis of disease for the global healthcare. The minimal requirements for the POC blood-testing device are blood microsampling, blood separation, immunoassay, and detection and communication of the signals. The microsampling of the blood can be achieved by specialized needle, which can be connected to the microchip or analytical devices. The sampled blood is then separated using either a filter (weir or pillar type), or by the phenomena unique to microfluidic system. The separated blood should then go through sandwich, homogeneous non-competitive, or competitive immunoassay, which can effectively diagnose diverse diseases. Lastly, the device should detect and translate the immune-signals to readable, and clinically significant signals. The development of such device will play a great role for improving healthcare technology.
随着即时诊断设备越来越受欢迎,本文提出了一种用于全球医疗保健的小型化检测设备,可实现从一滴血到疾病诊断。即时检测血液检测设备的最低要求是血液微量采样、血液分离、免疫测定以及信号检测与通信。血液的微量采样可通过专门的针头实现,该针头可连接到微芯片或分析设备。然后使用过滤器(堰式或柱状)或微流体系统特有的现象对采集的血液进行分离。分离后的血液应进行夹心免疫测定、均相非竞争性免疫测定或竞争性免疫测定,这些方法可有效诊断多种疾病。最后,该设备应检测免疫信号并将其转换为可读的、具有临床意义的信号。这种设备的开发将对改善医疗技术发挥重要作用。